172 related articles for article (PubMed ID: 15065635)
1. Safety and adverse effects of androgens: how to counsel patients.
Basaria S; Dobs AS
Mayo Clin Proc; 2004 Apr; 79(4 Suppl):S25-32. PubMed ID: 15065635
[TBL] [Abstract][Full Text] [Related]
2. Formulations and use of androgens in women.
Chu MC; Lobo RA
Mayo Clin Proc; 2004 Apr; 79(4 Suppl):S3-7. PubMed ID: 15065631
[TBL] [Abstract][Full Text] [Related]
3. Safety of estrogen/androgen regimens.
Simon JA
J Reprod Med; 2001 Mar; 46(3 Suppl):281-90. PubMed ID: 11304876
[TBL] [Abstract][Full Text] [Related]
4. Androgens and antiandrogens.
Schneider HP
Ann N Y Acad Sci; 2003 Nov; 997():292-306. PubMed ID: 14644837
[TBL] [Abstract][Full Text] [Related]
5. Testosterone for women: necessary or noxious?
Katz A
AWHONN Lifelines; 2006; 10(3):208-9. PubMed ID: 16792707
[No Abstract] [Full Text] [Related]
6. Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies.
Braunstein GD
J Sex Med; 2007 Jul; 4(4 Pt 1):859-66. PubMed ID: 17627735
[TBL] [Abstract][Full Text] [Related]
7. Clinical review: Controversies regarding transdermal androgen therapy in postmenopausal women.
Basaria S; Dobs AS
J Clin Endocrinol Metab; 2006 Dec; 91(12):4743-52. PubMed ID: 16984993
[TBL] [Abstract][Full Text] [Related]
8. Androgen replacement therapy in women.
Cameron DR; Braunstein GD
Fertil Steril; 2004 Aug; 82(2):273-89. PubMed ID: 15302268
[TBL] [Abstract][Full Text] [Related]
9. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
10. Androgens and breast cancer risk.
Kenemans P; van der Mooren MJ
Gynecol Endocrinol; 2012 Mar; 28 Suppl 1():46-9. PubMed ID: 22394304
[TBL] [Abstract][Full Text] [Related]
11. Safety of testosterone use in women.
Shufelt CL; Braunstein GD
Maturitas; 2009 May; 63(1):63-6. PubMed ID: 19250779
[TBL] [Abstract][Full Text] [Related]
12. Testosterone for women's sexual health disorders: making our voices heard.
Martinez L
AWHONN Lifelines; 2006; 10(3):210-1. PubMed ID: 16862728
[No Abstract] [Full Text] [Related]
13. Androgen deficiency in women.
Miller KK
J Clin Endocrinol Metab; 2001 Jun; 86(6):2395-401. PubMed ID: 11397829
[TBL] [Abstract][Full Text] [Related]
14. Androgen therapy in women: for whom and when.
Pluchino N; Carmignani A; Cubeddu A; Santoro A; Cela V; Errasti T
Arch Gynecol Obstet; 2013 Oct; 288(4):731-7. PubMed ID: 23912530
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum testosterone, hirsutism, and virilism associated with combined androgen-estrogen hormone replacement therapy.
Urman B; Pride SM; Yuen BH
Obstet Gynecol; 1991 Apr; 77(4):595-8. PubMed ID: 2002984
[TBL] [Abstract][Full Text] [Related]
16. [Female androgen insufficiency and potential risks of therapeutic replacement].
Leão LM; Duarte MP; Farias ML
Arq Bras Endocrinol Metabol; 2005 Apr; 49(2):205-16. PubMed ID: 16184248
[TBL] [Abstract][Full Text] [Related]
17. Androgen treatment in women.
Davis SR
Med J Aust; 1999 Jun; 170(11):545-9. PubMed ID: 10397047
[TBL] [Abstract][Full Text] [Related]
18. The role of androgens in hormone replacement therapy.
Johnson CE; Berman JR
Expert Opin Pharmacother; 2005 Sep; 6(11):1815-31. PubMed ID: 16144503
[TBL] [Abstract][Full Text] [Related]
19. The role of androgens in female sexual dysfunction.
Shifren JL
Mayo Clin Proc; 2004 Apr; 79(4 Suppl):S19-24. PubMed ID: 15065634
[TBL] [Abstract][Full Text] [Related]
20. Risks of menopausal androgen supplementation.
Slayden SM
Semin Reprod Endocrinol; 1998; 16(2):145-52. PubMed ID: 9711680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
